GHRL and metabolic dysfunction-associated steatotic liver disease: Khaleel et al. reported that administration of obestatin protects against NAFLD, reduces accumulation of lipids in the liver, and develops hepatomegaly, hyperlipidemia, and insulin resistance [59].